|
شركة Aethlon Medical، Inc. (AEMD) تقييم DCF |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Aethlon Medical, Inc. (AEMD) Bundle
تقييم آفاق Aethlon Medical ، Inc. (AEMD) مثل الخبير! توفر لك حاسبة DCF (AEMD) هذه البيانات المالية المملوءة مسبقًا والمرونة في تخصيص نمو الإيرادات ، WACC ، الهوامش ، وغيرها من الافتراضات الأساسية التي تتماشى مع تنبؤاتك.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2021 |
AY2 2022 |
AY3 2023 |
AY4 2024 |
AY5 2025 |
FY1 2026 |
FY2 2027 |
FY3 2028 |
FY4 2029 |
FY5 2030 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .7 | .3 | .6 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Revenue Growth, % | 0 | -55.37 | 95.21 | -100 | 0 | -15.04 | -15.04 | -15.04 | -15.04 | -15.04 |
| EBITDA | -7.9 | -10.3 | -11.7 | -11.8 | -13.0 | .0 | .0 | .0 | .0 | .0 |
| EBITDA, % | -1191.31 | -3500.42 | -2030.14 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Depreciation | .0 | .1 | .2 | .4 | .3 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 6.06 | 42.05 | 41.95 | 100 | 100 | 58.01 | 58.01 | 58.01 | 58.01 | 58.01 |
| EBIT | -7.9 | -10.4 | -11.9 | -12.2 | -13.4 | .0 | .0 | .0 | .0 | .0 |
| EBIT, % | -1197.37 | -3542.46 | -2072.09 | 100 | 100 | -20 | -20 | -20 | -20 | -20 |
| Total Cash | 9.9 | 17.1 | 14.5 | 5.4 | 5.5 | .0 | .0 | .0 | .0 | .0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .1 | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables, % | 22.62 | 43.5 | 0 | 100 | 100 | 53.22 | 53.22 | 53.22 | 53.22 | 53.22 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0 | 0 | 100 | 100 | 40 | 40 | 40 | 40 | 40 |
| Accounts Payable | .3 | .5 | .4 | .8 | .5 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 51.23 | 169.96 | 75.38 | 100 | 100 | 85.32 | 85.32 | 85.32 | 85.32 | 85.32 |
| Capital Expenditure | -.1 | -.3 | -.9 | -.3 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | -9.09 | -118.71 | -164.23 | 100 | 100 | -41.82 | -41.82 | -41.82 | -41.82 | -41.82 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -7.9 | -10.4 | -11.9 | -12.2 | -13.4 | .0 | .0 | .0 | .0 | .0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -7.7 | -10.5 | -12.5 | -11.8 | -13.3 | -.5 | .0 | .0 | .0 | .0 |
| WACC, % | 9.92 | 9.92 | 9.92 | 9.92 | 9.92 | 9.92 | 9.92 | 9.92 | 9.92 | 9.92 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -.5 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | -5 | |||||||||
| Equity Value | 4 | |||||||||
| Diluted Shares Outstanding, MM | 2 | |||||||||
| Equity Value Per Share | 2.80 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real AEMD financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe how your inputs affect Aethlon Medical’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Customizable Financial Inputs: Adjust essential variables such as revenue projections, operating margins, and R&D expenditures.
- Instant DCF Valuation: Quickly computes intrinsic value, net present value (NPV), and other financial metrics.
- High-Precision Results: Incorporates Aethlon Medical’s actual financial data for accurate valuation assessments.
- Effortless Scenario Testing: Evaluate various scenarios and analyze results with ease.
- Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download: Obtain the pre-configured Excel file containing Aethlon Medical, Inc.'s (AEMD) financial data.
- Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
- Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various forecasts and evaluate results immediately.
- Make Decisions: Leverage the valuation insights to shape your investment approach.
Why Choose This Calculator for Aethlon Medical, Inc. (AEMD)?
- Accurate Data: Up-to-date Aethlon financials provide dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Built-in calculations save you the effort of starting from the ground up.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Simple design and detailed instructions ensure accessibility for all users.
Who Should Use Aethlon Medical, Inc. (AEMD)?
- Investors: Gain insights into innovative medical technologies to make informed investment choices.
- Healthcare Analysts: Streamline your analysis with comprehensive data on Aethlon's products and market potential.
- Consultants: Easily modify presentations or reports to showcase Aethlon's strategic advantages to clients.
- Medical Researchers: Enhance your understanding of cutting-edge therapies and their implications in the healthcare landscape.
- Educators and Students: Utilize real-world case studies from Aethlon to enrich finance and medical curricula.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled Aethlon Medical, Inc. (AEMD) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for Aethlon Medical, Inc. (AEMD).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.